Spruce Biosciences Stock Price Prediction
| SPRB Stock | USD 0.48 0.01 2.04% |
Oversold Vs Overbought
51
Oversold | Overbought |
EPS Estimate Next Quarter (0.25) | EPS Estimate Current Year (0.96) | EPS Estimate Next Year (0.94) | Wall Street Target Price 2.3333 | EPS Estimate Current Quarter (0.24) |
Using Spruce Biosciences hype-based prediction, you can estimate the value of Spruce Biosciences from the perspective of Spruce Biosciences response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Spruce Biosciences to buy its stock at a price that has no basis in reality. In that case, they are not buying Spruce because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Spruce Biosciences after-hype prediction price | USD 0.48 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Spruce |
Spruce Biosciences After-Hype Price Prediction Density Analysis
As far as predicting the price of Spruce Biosciences at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Spruce Biosciences or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Spruce Biosciences, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Spruce Biosciences Estimiated After-Hype Price Volatility
In the context of predicting Spruce Biosciences' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Spruce Biosciences' historical news coverage. Spruce Biosciences' after-hype downside and upside margins for the prediction period are 0.02 and 3.61, respectively. We have considered Spruce Biosciences' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Spruce Biosciences is risky at this time. Analysis and calculation of next after-hype price of Spruce Biosciences is based on 3 months time horizon.
Spruce Biosciences Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Spruce Biosciences is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Spruce Biosciences backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Spruce Biosciences, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.02 | 3.13 | 0.00 | 0.00 | 8 Events / Month | 7 Events / Month | In about 8 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.48 | 0.48 | 0.00 |
|
Spruce Biosciences Hype Timeline
Spruce Biosciences is at this time traded for 0.48. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Spruce is projected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is projected to be very small, whereas the daily expected return is at this time at 0.02%. %. The volatility of related hype on Spruce Biosciences is about 12520.0%, with the expected price after the next announcement by competition of 0.48. About 41.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 0.39. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Spruce Biosciences recorded a loss per share of 0.95. The entity had not issued any dividends in recent years. Given the investment horizon of 90 days the next projected press release will be in about 8 days. Check out Spruce Biosciences Basic Forecasting Models to cross-verify your projections.Spruce Biosciences Related Hype Analysis
Having access to credible news sources related to Spruce Biosciences' direct competition is more important than ever and may enhance your ability to predict Spruce Biosciences' future price movements. Getting to know how Spruce Biosciences' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Spruce Biosciences may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| INZY | Inozyme Pharma | (0.16) | 8 per month | 0.00 | (0.27) | 5.68 | (7.92) | 16.62 | |
| DAWN | Day One Biopharmaceuticals | 0.23 | 9 per month | 2.72 | (0.04) | 3.84 | (3.69) | 11.44 | |
| TERN | Terns Pharmaceuticals | (0.11) | 11 per month | 0.00 | (0.09) | 5.68 | (5.96) | 34.09 | |
| ELDN | Eledon Pharmaceuticals | 0.17 | 5 per month | 3.04 | 0.09 | 10.09 | (4.24) | 28.12 | |
| HOOK | Hookipa Pharma | 0.09 | 7 per month | 0.00 | (0.36) | 4.05 | (7.24) | 22.98 | |
| XFOR | X4 Pharmaceuticals | 0.02 | 7 per month | 0.00 | (0.08) | 6.90 | (10.61) | 62.35 | |
| ABOS | Acumen Pharmaceuticals | (0.10) | 4 per month | 0.00 | (0.06) | 7.52 | (6.67) | 28.07 | |
| VECT | VectivBio Holding AG | 0.06 | 7 per month | 0.88 | 0.19 | 5.61 | (3.08) | 39.30 |
Spruce Biosciences Additional Predictive Modules
Most predictive techniques to examine Spruce price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Spruce using various technical indicators. When you analyze Spruce charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Spruce Biosciences Predictive Indicators
The successful prediction of Spruce Biosciences stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Spruce Biosciences, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Spruce Biosciences based on analysis of Spruce Biosciences hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Spruce Biosciences's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Spruce Biosciences's related companies. | 2023 | 2024 (projected) | Interest Debt Per Share | 0.0992 | 0.0943 | Revenue Per Share | 0.24 | 0.21 |
Story Coverage note for Spruce Biosciences
The number of cover stories for Spruce Biosciences depends on current market conditions and Spruce Biosciences' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Spruce Biosciences is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Spruce Biosciences' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Spruce Biosciences Short Properties
Spruce Biosciences' future price predictability will typically decrease when Spruce Biosciences' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Spruce Biosciences often depends not only on the future outlook of the potential Spruce Biosciences' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Spruce Biosciences' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 38.5 M | |
| Cash And Short Term Investments | 96.3 M |
Complementary Tools for Spruce Stock analysis
When running Spruce Biosciences' price analysis, check to measure Spruce Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Spruce Biosciences is operating at the current time. Most of Spruce Biosciences' value examination focuses on studying past and present price action to predict the probability of Spruce Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Spruce Biosciences' price. Additionally, you may evaluate how the addition of Spruce Biosciences to your portfolios can decrease your overall portfolio volatility.
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |